Dimensional Fund Advisors’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-132,385
| Closed | -$271K | – | 3550 |
|
2022
Q1 | $271K | Buy |
132,385
+67,762
| +105% | +$139K | ﹤0.01% | 3266 |
|
2021
Q4 | $186K | Hold |
64,623
| – | – | ﹤0.01% | 3355 |
|
2021
Q3 | $274K | Buy |
64,623
+11,311
| +21% | +$48K | ﹤0.01% | 3294 |
|
2021
Q2 | $282K | Sell |
53,312
-1,554
| -3% | -$8.22K | ﹤0.01% | 3271 |
|
2021
Q1 | $255K | Hold |
54,866
| – | – | ﹤0.01% | 3248 |
|
2020
Q4 | $181K | Hold |
54,866
| – | – | ﹤0.01% | 3234 |
|
2020
Q3 | $182K | Hold |
54,866
| – | – | ﹤0.01% | 3211 |
|
2020
Q2 | $185K | Sell |
54,866
-8,462
| -13% | -$28.5K | ﹤0.01% | 3217 |
|
2020
Q1 | $243K | Buy |
63,328
+8,462
| +15% | +$32.5K | ﹤0.01% | 3179 |
|
2019
Q4 | $331K | Sell |
54,866
-1,077
| -2% | -$6.5K | ﹤0.01% | 3195 |
|
2019
Q3 | $423K | Hold |
55,943
| – | – | ﹤0.01% | 3172 |
|
2019
Q2 | $758K | Hold |
55,943
| – | – | ﹤0.01% | 3112 |
|
2019
Q1 | $303K | Hold |
55,943
| – | – | ﹤0.01% | 3255 |
|
2018
Q4 | $166K | Sell |
55,943
-6,727
| -11% | -$20K | ﹤0.01% | 3307 |
|
2018
Q3 | $511K | Hold |
62,670
| – | – | ﹤0.01% | 3178 |
|
2018
Q2 | $610K | Buy |
62,670
+6,195
| +11% | +$60.3K | ﹤0.01% | 3094 |
|
2018
Q1 | $491K | Hold |
56,475
| – | – | ﹤0.01% | 3113 |
|
2017
Q4 | $707K | Buy |
+56,475
| New | +$707K | ﹤0.01% | 3048 |
|